Phase 2CompletedINTERVENTIONAL
Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients
ClinicalTrials.gov · NCT02916433 · Registry updated: 2020-10-08
- Condition / research focus
- Octreotide; Sputum
- Sponsor
- Danbury Hospital
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2016-09. Completion: 2019-02 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Octreotide (drug) — also listed as: Sandostatin, Sandostatin LAR
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Danbury Hospital
Danbury, Connecticut, United States
Site recruitment: Not reported